Both in Pharmaceuticals
BridgeBio Oncology Therapeutics vs Prelude Therapeutics Incorporated
Over the past year BBOT returned −65.8% and PRLD returned +189.1%; their daily moves had a correlation of 0.18.
BBOT −65.8% PRLD +189.1%Growth of $1, one year, split-adjusted
| Metric | BBOT | PRLD |
|---|---|---|
| Price | $3.92 | $3.96 |
| Market cap | $314.3M | $316.0M |
| Today | +2.89% | +1.28% |
| 1 month | −55.1% | −27.6% |
| 6 months | −54.8% | +29.0% |
| Year to date | −68.7% | +36.6% |
| 1 year | −66.5% | +164.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −244.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 14.1× |
| Net cash | $225.7M | $151.8M |
| Dividend yield | — | — |
| Volatility (60d) | 89.1% | 84.1% |
| Short % of float | 14.5% | 21.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).